Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $794.18 billion, total revenue of $166.43 billion and a weighted average PE ratio of 53.17.
Market Cap
794.18B
Revenue
166.43B
Profits
14.94B
PE Ratio
53.17
Profit Margin
8.97%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 215.72B | -0.18% | 353,791 | 43.74B |
| 2 | DHR | Danaher Corporation | 160.52B | 0.05% | 840,030 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 57.17B | -0.21% | 76,924 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 41.38B | -1.43% | 484,996 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 38.16B | -0.38% | 407,017 | 15.90B |
| 6 | NTRA | Natera, Inc. | 33.80B | 1.18% | 568,529 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.94B | -0.43% | 20,600 | 3.94B |
| 8 | WAT | Waters Corporation | 23.52B | -0.35% | 118,878 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.44B | -1.11% | 168,158 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.35B | -0.70% | 154,219 | 10.85B |
| 11 | ILMN | Illumina, Inc. | 19.68B | 0.61% | 171,889 | 4.29B |
| 12 | EXAS | Exact Sciences Corporation | 19.20B | 0.03% | 2,243,875 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.40B | 0.36% | 80,399 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 14.27B | 0.60% | 372,322 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 13.36B | -4.42% | 1,108,543 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 11.60B | -0.21% | 130,466 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 10.20B | -0.07% | 232,908 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.06B | 0.02% | 198,556 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 6.11B | -2.26% | 115,141 | 1.97B |
| 20 | BLLN | BillionToOne, Inc. | 5.09B | 7.77% | 60,040 | 209.03M |
| 21 | SHC | Sotera Health Company | 4.71B | 0.12% | 1,129,412 | 1.15B |
| 22 | WGS | GeneDx Holdings Corp. | 4.59B | -1.86% | 112,726 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.95B | -3.26% | 220,925 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.67B | -2.19% | 365,906 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.99B | -1.01% | 250,704 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.55B | -1.73% | 179,003 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.30B | 0.93% | 284,306 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.13B | -2.36% | 185,353 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.03B | -0.37% | 295,202 | 642.07M |
| 30 | CDNA | CareDx, Inc | 960.25M | -3.81% | 182,388 | 358.00M |
| 31 | FLGT | Fulgent Genetics, Inc. | 862.15M | -1.45% | 41,847 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 852.52M | -8.40% | 535,793 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 666.48M | -2.46% | 128,798 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 230.55M | -1.65% | 65,332 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 215.33M | -2.68% | 29,373 | 75.75M |
| 36 | MDXH | MDxHealth SA | 179.73M | -0.24% | 24,759 | 103.07M |
| 37 | XGN | Exagen Inc. | 167.73M | -1.19% | 53,748 | 63.60M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 154.93M | -3.14% | 10,220 | 4.40M |
| 39 | FONR | FONAR Corporation | 95.32M | -0.65% | 10,731 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 64.84M | -4.57% | 52,666 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 43.11M | -0.03% | 6,722 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 29.55M | -2.15% | 89,299 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 9.95M | -2.83% | 35,293 | - |
| 44 | ADVB | Advanced Biomed Inc. | 8.03M | -2.42% | 23,282 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.68M | -0.58% | 28,903 | 6.78M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 6.79M | 5.84% | 31,831 | - |
| 47 | MYNZ | Mainz Biomed N.V. | 6.39M | 0.85% | 44,242 | 659.94K |
| 48 | PRPH | ProPhase Labs, Inc. | 6.37M | -1.50% | 1,729,627 | 5.06M |
| 49 | ISPC | iSpecimen Inc. | 4.66M | -1.89% | 36,021 | 3.35M |
| 50 | XWEL | XWELL, Inc. | 4.61M | 2.92% | 4,751 | 29.52M |